Marketed medicines for PCOS are mostly drugs (39 drugs versus six biologics), all repurposed
These senescent cell clearance research findings have significant implications for anti-aging intervention development, chemotherapy recovery support, and understanding how cellular senescence contributes to age-related tissue dysfunction and disease pathogenesis
Not for human use, medical use, diagnostic use, or veterinary use
Gender-specific association of SLC19A1 and MTHFR genetic polymorphism with oxidative stress biomarkers and plasma folate levels in older adults
The FDA has identified concerns with compounded BPC-157, including possible immunogenicity risks, peptide-related impurities, and limited safety information for proposed routes of administration